Global Pharyngitis Therapeutics Market
According to Intent Market Research, the Pharyngitis Therapeutics Market is expected to grow from USD 4.8 Billion in 2024-e at a CAGR of 11.3% to touch USD 9.0 Billion by 2030. The Pharyngitis Therapeutics Market is dominated by key players such as Sanofi SA, Pfizer Inc., AstraZeneca PLC, Johnson & Johnson, Novartis AG, and Merck & Co., Inc.